SCHEMBL19455992

SCHEMBL19455992

COC1(OC)CCC(NN)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26487771 0.72 EPHX2 (0.37)
SCHEMBL1717640 0.72 EPHX2 (0.36)
SCHEMBL11668299 0.70
Hydrochloric Acid SCHEMBL15540415 0.70 EPHX2 (0.36)
Hydrochloric Acid SCHEMBL15550997 0.70 EPHX2 (0.35)
SCHEMBL7220261 0.69
SCHEMBL4885580 0.68
SCHEMBL6677245 0.67 TSHR (0.33)
SCHEMBL7220256 0.67
SCHEMBL6676256 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230058545-A1 HCK AS A THERAPEUTIC TARGET IN MYD88 MUTATED DISEASES DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-02-23 US disclosed
US-20170291890-A1 HETEROCYCLE SUBSTITUTED AMINO-PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF Epizyme, Inc. 2017-10-12 US disclosed